During ECCO 2024, held from February 21st to 24th, international IBD specialists came to Stockholm to present the latest news in IBD care. In this setting, our colleagues Oliver Dähn and Christian Reinhard had the privilege of presenting the following two posters: Poster 1: P437 - Feasibility study of a Point-of-Care assay for rapid
Continue Reading →
- info@buhlmannlabs.ch
- +41 61 487 12 12
Blog Archives
Learn how Dr. Bernard Royer from the Clinical Pharmacology and Toxicology Service at the Centre Hospitalier Universitaire de Besançon, France, significantly improved turnaround time and streamlined testing processes by adopting the BÜHLMANN therapeutic drug monitoring assays.
Discover insightful posters from BÜHLMANN focusing on calprotectin assay standardization, presented at the United European Gastroenterology Week 2023!
Completion of 10 application notes for our new turbidimetric immunoassay: BÜHLMANN sCAL® turbo – a fast, inexpensive and reliable biomarker of inflammation in blood serum!
Social Links